Virus de la gripe
Los inhibidores del virus de la gripe son compuestos que interfieren con la replicación y propagación de los virus de la gripe. Estos inhibidores son vitales en la investigación de estrategias antivirales, la comprensión del ciclo de vida del virus de la gripe y el desarrollo de tratamientos y vacunas eficaces. Los inhibidores de la gripe pueden dirigirse a varias etapas del proceso de replicación viral, incluyendo la entrada viral, la replicación y la liberación. En CymitQuimica, ofrecemos una amplia gama de inhibidores de alta calidad del virus de la gripe para apoyar su investigación en virología, enfermedades infecciosas y desarrollo de medicamentos antivirales.
Se han encontrado 296 productos de "Virus de la gripe"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Anti-Influenza agent 4
CAS:<p>Anti-Influenza agent 4 selectively inhibits A/Parma (EC50: 62 nM) and A/Roma (EC50: 150 nM) influenza strains.</p>Fórmula:C19H18N2O5SPureza:98.94% - 98.95%Forma y color:SolidPeso molecular:386.42NS1-IN-1
CAS:<p>NS1-IN-1: Potent NS1 inhibitor, antiviral, reduces viral proteins by inhibiting mTORC1 via TSC1-TSC2, limits replication.</p>Fórmula:C23H26N2O4Pureza:98.71%Forma y color:SolidPeso molecular:394.46Laninamivir Octanoate Monohydrate
CAS:<p>Laninamivir Octanoate Monohydrate is a neuraminidase inhibitor.</p>Fórmula:C21H38N4O9Pureza:98%Forma y color:SolidPeso molecular:490.55(Rac)-CP-609754
CAS:<p>LNK754 is a farnesyltransferase inhibitor. It is used for the treatment of cancer and Alzheimer's disease.</p>Fórmula:C29H22ClN3O2Pureza:98%Forma y color:SolidPeso molecular:479.96Antiviral agent 43
CAS:<p>Antiviral agent 43 (compound 16) serves as a potent, orally active inhibitor of influenza A virus entry, demonstrating efficacy by inhibiting the replication of the influenza A strains VH04-H5N1 and PR8-H1N1 with EC50 values of 240 nM and 72 nM, respectively [1].</p>Fórmula:C17H22ClF3N2OForma y color:SolidPeso molecular:362.82Cap-dependent endonuclease-IN-13
CAS:<p>Cap-dependent endonuclease-IN-13 is a potent inhibitor of cap-dependent endonuclease (CEN) and shows research potential against influenza virus infection (</p>Fórmula:C25H20F2N4O4SForma y color:SolidPeso molecular:510.51Influenza virus-IN-6
CAS:<p>Influenza virus-IN-6 (Compound 35) serves as a potent inhibitor targeting the N-terminal domain of the polymerase acidic protein (PA N ) endonuclease subunit of</p>Fórmula:C27H26ClNO7Pureza:98%Forma y color:SolidPeso molecular:511.95L-742001 Hydrochloride
CAS:<p>L-742001 Hydrochloride is an RNA polymerase inhibitor.</p>Fórmula:C23H25Cl2NO4Forma y color:SolidPeso molecular:450.36DU-34569 Maleate
CAS:<p>DU-34569 Maleate, an antiviral agent, acts against influenza A, parainfluenza Sendai, coxsackie A21, and rhinovirus.</p>Fórmula:C18H27NO4Pureza:98%Forma y color:SolidPeso molecular:321.41RO-7
CAS:<p>RO-7 is a next-generation polymerase (PA) endonuclease influenza A and B viruses inhibitor.</p>Fórmula:C24H20F3N3O3SPureza:98%Forma y color:SolidPeso molecular:487.49JNJ4796
CAS:<p>JNJ4796 is an oral fusion inhibitor that neutralizes influenza A group 1 by blocking HA-mediated fusion, mimicking bnAbs.</p>Fórmula:C28H27N9O3Pureza:98%Forma y color:SolidPeso molecular:537.57Tirfipiravir
CAS:<p>Tirapiravir is an antiviral nucleoside analog that exhibits activity against both the novel coronavirus and influenza virus [1].</p>Fórmula:C14H17N3O8Pureza:98%Forma y color:SolidPeso molecular:355.3EHNA hydrochloride
CAS:<p>EHNA hydrochloride is a PDE2 and ADA inhibitor with anticancer activity, increasing intracellular adenosine concentration in a treatment time-dependent manner.</p>Fórmula:C14H24ClN5OPureza:98%Forma y color:SolidPeso molecular:313.83Antiviral agent 35
CAS:<p>Antiviral agent 35 (compound 4d) serves as a potent orally active inhibitor of the influenza virus, targeting early stages of viral replication.</p>Fórmula:C23H18N2O4SPureza:98%Forma y color:SolidPeso molecular:418.47XSJ2-46
CAS:<p>XSJ2-46, a 5'-amino NI analog, is an antiviral agent possessing anti-Zika virus properties and demonstrates reasonable inhibition of RNA-dependent RNA</p>Fórmula:C25H24ClF3N6O3Pureza:98%Forma y color:SolidPeso molecular:548.953,4'-Dihydroxyflavone
CAS:<p>3,4'-Dihydroxyflavone (3,4'-DHF) is an oral active flavonoid. 3,4'-Dihydroxyflavone (3,4'-DHF) shows antiviral activity against Influenza A virus.</p>Fórmula:C15H10O4Pureza:98.33%Forma y color:SolidPeso molecular:254.243M-011
CAS:<p>3M-011: potent TLR7/8 agonist, cytokine inducer, enhances radiotherapy, fights H3N2, and has anti-tumor effects.</p>Fórmula:C18H25N5O3SPureza:98%Forma y color:SolidPeso molecular:391.49EBOV-IN-1
CAS:<p>EBOV-IN-1 is an adamantane dipeptide piperazine inhibitor of Ebola virus (EBOV) that inhibits EBOV infection and suppresses pseudotypic EBOV infection.</p>Fórmula:C34H43N3O5Pureza:98.62% - 98.92%Forma y color:SolidPeso molecular:573.72Massarilactone H
CAS:<p>Massarilactone H, a polyketide, is a neuraminidase inhibitor, with an IC 50 of 8.18 µM .</p>Fórmula:C11H12O5Forma y color:SolidPeso molecular:224.21Flutimide
CAS:<p>Flutimide: Endonuclease inhibitor, IC50 = 3μM, for research on acute respiratory diseases like influenza.</p>Fórmula:C12H18N2O3Forma y color:SolidPeso molecular:238.28Saussureamine C
CAS:<p>Saussureamine C is an inhibitor of H274Y and N294S mutants.</p>Fórmula:C19H26N2O5Forma y color:SolidPeso molecular:362.42Neuraminidase-IN-11
<p>Neuraminidase-IN-11 (15e) inhibits H1N1 (IC50: 4.7nM), H5N1 (8.46nM), H5N8 viruses (1.5nM) selectively & potently.</p>Forma y color:SolidNeuraminidase-IN-4
<p>Neuraminidase-IN-4 inhibits neuraminidase (EC50: 1.59 μM) and has strong anti-H5N1 activity.</p>Fórmula:C21H20N2O6SForma y color:SolidPeso molecular:428.46Carbodine
CAS:<p>Carbodine is an antiviral targeting CTP synthetase, effective against influenza A0/PR-8/34 and A2/Aichi/2/68.</p>Fórmula:C10H15N3O4Pureza:98%Forma y color:SolidPeso molecular:241.24RdRP-IN-5
CAS:<p>RdRP-IN-5 (compound 20), a potent inhibitor of the influenza virus RNA-dependent RNA polymerase (RdRP), has potential application in influenza research [1].</p>Fórmula:C23H21N3O5Pureza:98%Forma y color:SolidPeso molecular:419.43Cap-dependent endonuclease-IN-17
CAS:<p>CEN inhibitor IN-17 targets influenza A/H3N2; IC50: 1.29 μM. From patent CN112898346A, DSC701.</p>Fórmula:C24H20F2N3O7PSForma y color:SolidPeso molecular:563.47UNC0638 hydrate
CAS:UNC0638 hydrate selectively inhibits G9a and GLP histone methyltransferases with IC50 values of 15 nM and 19 nM, respectively. It is effective in inhibiting invasion and migration of TNBC cells in vitro. Additionally, UNC0638 hydrate acts as an inhibitor of EHMT1/2 and induces the expression of fetal hemoglobin (HbF) in cultures of human erythroid progenitor cells. Furthermore, it exhibits antiviral activity against FMDV (foot-and-mouth disease virus) and VSV (vesicular stomatitis virus), demonstrating remarkable potency and selectivity across various epigenetic and non-epigenetic targets.Fórmula:C30H49N5O3Forma y color:SolidPeso molecular:527.74Laninamivir trifluoroacetate
CAS:<p>Laninamivir trifluoroacetate, a long-acting antiviral, treats and prevents Influenza A and B via nasal spray.</p>Fórmula:C15H23F3N4O9Pureza:98%Forma y color:SolidPeso molecular:460.363Neuraminidase-IN-18
CAS:<p>Neuraminidase-IN-18 (compound N5), a novel polyheterocyclic neuraminidase (NA) inhibitor, demonstrates significant inhibitory activity against H5N1 NA, with an IC 50 of 0.14 μM against the wild-type H5N1 NA and 0.27 μM against the H5N1-H274Y mutant NA. This compound effectively binds to NAs, inhibiting influenza virus replication at the cellular level [1].</p>Fórmula:C22H18FN3O3SForma y color:SolidPeso molecular:423.46AV-5080
CAS:<p>AV-5080 is an orally active neuraminidase (neuraminidase) inhibitor that is utilized in the research of both Type A and Type B influenza viruses.</p>Fórmula:C15H25FN4O4Forma y color:SolidPeso molecular:344.38VV261
CAS:<p>VV261 is an orally active inhibitor of the Influenza Virus. It exhibits activity against the Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) and the Lymphocytic Choriomeningitis Virus (LCMV), with EC50 values of 0.89 and 0.15, respectively.</p>Fórmula:C28H34FN3O11Forma y color:SolidPeso molecular:607.58Cap-dependent endonuclease-IN-5
CAS:<p>Cap-dependent endonuclease-IN-5 inhibits CEN and fights influenza with low toxicity and good in vivo properties.</p>Fórmula:C27H21F2N3O4S2Forma y color:SolidPeso molecular:553.60cis-RdRP-IN-5
<p>Cis-RdRP-IN-5 is an effective inhibitor of the influenza virus RNA-dependent RNA polymerase (RdRP), employed in influenza virus research.</p>Fórmula:C23H21N3O5Forma y color:SolidPeso molecular:419.43Anti-Influenza agent 3
<p>Compound 11h: Potent, low-toxicity anti-influenza, inhibits M2 ion channels. EC50: 3.29μM (H3N2), 2.45μM (H1N1).</p>Fórmula:C16H22ClNOSForma y color:SolidPeso molecular:311.87Cap-dependent endonuclease-IN-10
CAS:<p>Cap-dependent endonuclease-IN-10, with low toxicity & good stability, effectively inhibits flu viruses and shows promise against A, B, C types.</p>Fórmula:C25H18F2N4O5SForma y color:SolidPeso molecular:524.50Cap-dependent endonuclease-IN-2
<p>Cap-dependent endonuclease-IN-2 strongly blocks influenza A virus RNA polymerase; it's a CEN inhibitor.</p>Fórmula:C30H24FN3O7SForma y color:SolidPeso molecular:589.59RdRP-IN-4
<p>RdRP-IN-4, an oral arylbenzohydrazide, inhibits influenza A/B by targeting PB1 of RdRP, with EC50s of 53 nM (H1N1) and 20 nM (Flu B), and aids infected mice.</p>Fórmula:C17H17Br2N3O2Forma y color:SolidPeso molecular:455.14Cap-dependent endonuclease-IN-6
CAS:<p>Cap-dependent endonuclease-IN-6 (compound 13) is a Cap-dependent endonuclease (CEN) inhibitor that inhibits influenza virus.</p>Fórmula:C23H21N3O3SForma y color:SolidPeso molecular:419.5trans-RdRP-IN-5
<p>Trans-RdRP-IN-5 is a potent inhibitor of the influenza virus RNA-dependent RNA polymerase (RdRP), with applications in influenza virus research.</p>Fórmula:C23H21N3O5Forma y color:SolidPeso molecular:419.43Cap-dependent endonuclease-IN-7
CAS:<p>Cap-dependent endonuclease-IN-7, a potent CEN inhibitor, blocks viral mRNA synthesis and virus spread, with research use for influenza A, B, C.</p>Fórmula:C36H28FN3O7SForma y color:SolidPeso molecular:665.69Cap-dependent endonuclease-IN-14
CAS:<p>Cap-dependent endonuclease-IN-14 hinders CEN and could treat influenza virus infections. (Patent CN113620948A, compound 1-c).</p>Fórmula:C30H23FN2O6SForma y color:SolidPeso molecular:558.58Cap-dependent endonuclease-IN-25
CAS:<p>Cap-dependent endonuclease-IN-25 is a potent inhibitor of CEN, useful in studying Orthomyxoviridae viruses. (See WO2020075080A1, compound 4.)</p>Fórmula:C25H25N3O3Forma y color:SolidPeso molecular:415.48Cap-dependent endonuclease-IN-1
CAS:<p>Cap-dependent endonuclease-IN-1: potent, oral inhibitor with antiviral properties against influenza.</p>Fórmula:C27H22F2N2O6SPureza:98.88% - 99.09%Forma y color:SolidPeso molecular:540.54UH15-38
CAS:<p>UH15-38 is a potent and selective RIPK3 inhibitor that blocks necroptosis in alveolar epithelial cells triggered by IAV, useful for studying lung inflammation.</p>Fórmula:C26H27N5O2Pureza:99.85%Forma y color:SolidPeso molecular:441.53FGI-106 tetrahydrochloride
CAS:<p>FGI-106 tetrahydrochloride demonstrates potent inhibitory activity across a broad spectrum of viruses, including those causing hemorrhagic fevers such as Ebola</p>Fórmula:C28H42Cl4N6Pureza:99.68%Forma y color:SolidPeso molecular:604.48Cap-dependent endonuclease-IN-9
CAS:<p>Cap-dependent endonuclease-IN-9, a strong influenza inhibitor, shows low toxicity, good pharmacokinetics, and dynamic action.</p>Fórmula:C29H22F2N4O7SPureza:98%Forma y color:SolidPeso molecular:608.57Ref: TM-T72125
Producto descatalogado
